omniture
嘉兴和剂药业有限公司

Latest News

Angel Pharmaceuticals Announces Approval of IND Application for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China

JIAXING,China and BURLINGAME,Calif., Sept. 26, 2022 /PRNewswire/ -- Angel Pharmaceuticals Ltd. ("An...

2022-09-27 08:30 1396

Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818

JIAXING, China and BURLINGAME, Calif., Oct. 25, 2021 /PRNewswire/ -- Angel Pharmaceuticals Co., Ltd...

2021-10-26 07:30 1415

Angel Pharmaceuticals Announces IND Acceptance for Clinical Trial of ITK Inhibitor CPI-818 in China

JIAXING, China and BURLINGAME, Calif., Aug. 16, 2021 /PRNewswire/ -- Angel Pharmaceuticals Ltd. ("A...

2021-08-17 05:00 1549